nivolumab,ipilimumab
bms
[' ipi ', 'melanoma', 'nivo', 'ipi+']
meet outstanding resident reporting high dose ipi overcoming io resistance post pd of regular dose ipi+nivo in melanoma. future oncologist 
Melanoma and Cancer Immunotherapy Specialist, Physician Scientist